KA/EN
Register
Medicines reference
Search
Search
Product

Predso

Favourites

Prednisolone · Laboratorios Lansier

1 form: eye drops. In force in Georgia: 1 of 1 (human register).

Forms and doses1 of 1 in force in Georgia

Form Dose Frequency Georgia
1%, Eye drops No label dose in the reference yet - Georgia Yes, human
In force until 01 Dec 2028
Human (Ministry of Health, RAMA)
In the register: პრედსო 1%, თვალის წვეთები 5 მლ
№ რ-039657
Verified on: 16 Oct 2026
Details: pack, label wording, sources, registration

Predso 1%, Eye drops

eye drops 5 ml, human medicine
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Prednisolone acetate 1% for diagnosed noninfectious steroid-responsive conjunctival, corneal or anterior-segment inflammation after complete examination and a fluorescein-negative intact cornea
6.8/10
Situational / acceptable
vetman assessment

Predso

1%, eye drops 5 ml, human medicine
Assessed clinical scopeDog · Prednisolone acetate 1% for diagnosed noninfectious steroid-responsive conjunctival, corneal or anterior-segment inflammation after complete examination and a fluorescein-negative intact cornea · Into the eye
Care settingVeterinarian-directed clinic or home treatment after magnified ophthalmic examination, fluorescein staining and intraocular-pressure assessment where relevant, with early recheck and response-guided taper
vetman score 6.8/10 Situational / acceptable
Evidence confidence: Medium Georgia: Yes, human · № რ-039657 · Verified on 16 Oct 2026 Off-label use

A potent standard topical steroid for diagnosed noninfectious anterior ocular inflammation when the cornea is intact. Its value depends on examination and monitoring: stain before treatment, exclude or treat infection, shake every dose, monitor pressure and response, and stop if pain or corneal damage emerges.

Regulatory and scientific credibility6.0/10

This exact 1% human ophthalmic suspension has a sourced current Georgian registration and an official manufacturer page identifying its concentration, form and pack; exhaustive current checks record no exact EU/EEA, GB or US registration. Veterinary use is off-label.

Clinical efficacy8.5/10

Prednisolone acetate 1% is among the most effective cornea-penetrating topical corticosteroids used in veterinary ophthalmology. Guideline support covers noninfectious anterior uveitis, immune-mediated keratitis and episcleritis; canine pharmacokinetic and perioperative studies directly support ocular exposure and anti-inflammatory use, although diagnosis and cause control determine benefit.

Safety and tolerability5.5/10

Correct selection is usually locally tolerable, but 1% prednisolone delays epithelial repair, augments collagenase and can worsen an occult ulcer or infection. Four-times-daily bilateral use produces measurable systemic exposure and HPA-axis suppression; repeated treatment can raise intraocular pressure and cause infection, cataract or steroid keratopathy.

Clinical practicality7.5/10

The 5 ml suspension gives a directly deliverable ocular dose and limits pack waste, but it must be shaken thoroughly before every use. Frequent initial dosing, atraumatic restraint, tip hygiene, spacing other drops and scheduled re-examination remain material burdens.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Perform fluorescein staining before starting and whenever new pain develops. Do not use topical prednisolone with a corneal abrasion, ulcer, descemetocele, melting ulcer, perforation or unhealed penetrating injury; it delays epithelial repair and can accelerate collagenolysis.
  • Do not use as steroid monotherapy for an undiagnosed red eye or untreated bacterial, fungal, mycobacterial, parasitic or viral ocular infection. Establish and treat the cause; immunosuppression can mask progression and rapidly compromise the cornea.
  • Stop treatment and reassess urgently if blepharospasm, discharge, corneal clouding, focal staining, vision change or worsening redness develops.
  • Measure intraocular pressure when glaucoma is possible and during repeated or prolonged treatment. Prednisolone acetate can raise pressure, cause glaucoma or cataract and promote steroid keratopathy; monitor cornea, lens and response instead of renewing indefinitely.
  • Ophthalmic prednisolone is systemically absorbed and four-times-daily bilateral dosing can suppress the HPA axis. Use the lowest effective frequency, consider nasolacrimal occlusion, and review diabetes, hyperadrenocorticism, infection risk and concurrent systemic corticosteroids.
  • Use an indication-appropriate initial frequency and recheck early; severe anterior inflammation may require frequent dosing, whereas chronic immune-mediated disease requires response-guided tapering. Do not stop a prolonged course abruptly or continue unchanged without confirming control.
  • This score covers diagnosed steroid-responsive anterior ocular inflammation as a clinical class, not every human-label claim and not posterior-segment disease that topical drops cannot adequately reach. Lack of response requires diagnostic reassessment, not automatic escalation.
  • Shake the suspension thoroughly before every dose. Avoid touching the dropper tip to the eye, lashes or skin; use one bottle per patient where contamination is plausible and separate different eye drops by several minutes.
  • Safety of these exact human products in pregnant or lactating dogs and cats has not been established. Use only after a documented veterinary benefit-risk assessment, especially for prolonged or bilateral treatment.
Assessment sources
  1. Predso official product identity2026
  2. Pred Forte 1% SmPC2024
  3. Prednisolone acetate 1% US label2025
  4. MSD ophthalmic steroids2026
  5. MSD anterior uvea2026
  6. Canine prednisolone tear PK2020
  7. Canine ophthalmic steroid absorption2022
  8. Prednisolone in diabetic dogs2019
  9. Feline steroid ocular hypertension1999
  10. ABCD feline herpesvirus guideline2009
  11. Canine steroid keratopathy2024
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Prednisolone acetate 1% for diagnosed noninfectious steroid-responsive conjunctival, corneal or anterior-segment inflammation after complete examination and a fluorescein-negative intact cornea
6.3/10
Situational / acceptable
vetman assessment

Predso

1%, eye drops 5 ml, human medicine
Assessed clinical scopeCat · Prednisolone acetate 1% for diagnosed noninfectious steroid-responsive conjunctival, corneal or anterior-segment inflammation after complete examination and a fluorescein-negative intact cornea · Into the eye
Care settingVeterinarian-directed clinic or home treatment after magnified ophthalmic examination, fluorescein staining and intraocular-pressure assessment where relevant, with early recheck and response-guided taper
vetman score 6.3/10 Situational / acceptable
Evidence confidence: Medium Georgia: Yes, human · № რ-039657 · Verified on 16 Oct 2026 Off-label use

A potent standard topical steroid for diagnosed noninfectious anterior ocular inflammation when the cornea is intact. Its value depends on examination and monitoring: stain before treatment, exclude or treat infection, shake every dose, monitor pressure and response, and stop if pain or corneal damage emerges.

Regulatory and scientific credibility6.0/10

This exact 1% human ophthalmic suspension has a sourced current Georgian registration and an official manufacturer page identifying its concentration, form and pack; exhaustive current checks record no exact EU/EEA, GB or US registration. Veterinary use is off-label.

Clinical efficacy7.5/10

Prednisolone acetate 1% is an established potent topical corticosteroid for selected noninfectious feline anterior ocular inflammation and anterior uveitis. Direct controlled feline efficacy evidence is limited, and common infectious or FHV-associated presentations can make an apparently inflammatory eye unsuitable for steroid treatment.

Safety and tolerability4.5/10

Corneal ulceration, untreated infection and FHV reactivation create serious local hazards. In cats, 1% prednisolone acetate increased intraocular pressure within days in a controlled model; longer or bilateral use may also delay healing, promote infection or cataract and produce systemic glucocorticoid exposure, while exact-product feline safety data are limited.

Clinical practicality7.5/10

The 5 ml suspension gives a directly deliverable ocular dose and limits pack waste, but it must be shaken thoroughly before every use. Frequent initial dosing, atraumatic restraint, tip hygiene, spacing other drops and scheduled re-examination remain material burdens.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Perform fluorescein staining before starting and whenever new pain develops. Do not use topical prednisolone with a corneal abrasion, ulcer, descemetocele, melting ulcer, perforation or unhealed penetrating injury; it delays epithelial repair and can accelerate collagenolysis.
  • Do not use as steroid monotherapy for an undiagnosed red eye or untreated bacterial, fungal, mycobacterial, parasitic or viral ocular infection. Establish and treat the cause; immunosuppression can mask progression and rapidly compromise the cornea.
  • Topical corticosteroids can reactivate latent feline herpesvirus and precipitate ulcerative keratitis or corneal sequestrum. In a compatible cat, stop steroid treatment and investigate or treat FHV-associated disease before further immunosuppression.
  • Measure intraocular pressure when glaucoma is possible and during repeated or prolonged treatment. Prednisolone acetate can raise pressure, cause glaucoma or cataract and promote steroid keratopathy; monitor cornea, lens and response instead of renewing indefinitely.
  • Ophthalmic prednisolone is systemically absorbed and four-times-daily bilateral dosing can suppress the HPA axis. Use the lowest effective frequency, consider nasolacrimal occlusion, and review diabetes, hyperadrenocorticism, infection risk and concurrent systemic corticosteroids.
  • Use an indication-appropriate initial frequency and recheck early; severe anterior inflammation may require frequent dosing, whereas chronic immune-mediated disease requires response-guided tapering. Do not stop a prolonged course abruptly or continue unchanged without confirming control.
  • This score covers diagnosed steroid-responsive anterior ocular inflammation as a clinical class, not every human-label claim and not posterior-segment disease that topical drops cannot adequately reach. Lack of response requires diagnostic reassessment, not automatic escalation.
  • Shake the suspension thoroughly before every dose. Avoid touching the dropper tip to the eye, lashes or skin; use one bottle per patient where contamination is plausible and separate different eye drops by several minutes.
  • Safety of these exact human products in pregnant or lactating dogs and cats has not been established. Use only after a documented veterinary benefit-risk assessment, especially for prolonged or bilateral treatment.
Assessment sources
  1. Predso official product identity2026
  2. Pred Forte 1% SmPC2024
  3. Prednisolone acetate 1% US label2025
  4. MSD ophthalmic steroids2026
  5. MSD anterior uvea2026
  6. Canine prednisolone tear PK2020
  7. Canine ophthalmic steroid absorption2022
  8. Prednisolone in diabetic dogs2019
  9. Feline steroid ocular hypertension1999
  10. ABCD feline herpesvirus guideline2009
  11. Canine steroid keratopathy2024
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Prednisolone10 mg/ml
Formulation Type
Eye drops
Administration route
Into the eye
Manufacturer
Laboratorios Lansier · Peru
Registration
Georgia Yes, human
In force until 01 Dec 2028
Human (Ministry of Health, RAMA)
In the register: პრედსო 1%, თვალის წვეთები 5 მლ
№ რ-039657
Verified on: 16 Oct 2026
 EU No
Verified on: 16 Oct 2026
 UK No
Verified on: 16 Oct 2026
 US No
Verified on: 16 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Active substance doses, with sources

Each dose comes with its source. Check the label of the product you use.

Active substance Prednisolone
Dose calculatorCalculates the active-substance amount; it is not a prescription.
PatientSpecies and weight will be filled in automatically in other calculators.
Selected dose
Dose Species Indication Route Frequency Source
0.1–2 mg/kg Dog, Cat Inflammation By mouth once daily
VMD SPC 2026
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Prednicare 5 mg Tablets - Summary of Product Characteristics
UK Veterinary Medicines Directorate, Product Information Database, 2026
0.5–4 mg/kg Dog, Cat Immune-Mediated Disease By mouth once daily
VMD SPC 2025
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Prednicortone 5 mg Tablets for Dogs and Cats - Summary of Product Characteristics
UK Veterinary Medicines Directorate, Product Information Database, 2025
0.5–1 mg/kg Dog, Cat Inflammation Intramuscular Single dose
VMD SPC 2023
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Cortico Veyxin 10 mg/ml Suspension for Injection - Summary of Product Characteristics
UK Veterinary Medicines Directorate, Product Information Database, 2023

Known Contraindications

  • Critical
    An uncontrolled viral, fungal, or parasitic infection is an absolute contraindication. The parasitic-infection restriction is specified on the Prednicare label.
  • Critical
    Diabetes mellitus is an absolute contraindication on the Prednicare and Prednicortone labels.
    Sources: Product label
  • Critical
    Hyperadrenocorticism is an absolute contraindication on the Prednicare and Prednicortone labels.
    Sources: Product label
  • Critical
    Osteoporosis is an absolute contraindication on the Prednicare and Prednicortone labels.
    Sources: Product label
  • Critical
    Corneal ulceration is an absolute contraindication on the Prednicare and Prednicortone labels.
    Sources: Product label
  • Critical
    Glaucoma is an absolute contraindication on the Prednicare and Prednicortone labels.
    Sources: Product label
  • Critical
    Hypersensitivity to prednisolone or any excipient is an absolute contraindication on the Prednicare and Prednicortone labels.
    Sources: Product label
  • Critical
    Burn injury is listed as a contraindication on the Prednicortone label but not on the other two reviewed labels.
    Sources: Product label
  • Critical
    Cataract is listed as a contraindication on the Cortico Veyxin label.
    Sources: Product label
  • Critical
    Hypocalcaemia is listed as a contraindication on the Cortico Veyxin label.
    Sources: Product label
  • Critical
    Hypertension is listed as a contraindication on the Cortico Veyxin label.
    Sources: Product label
  • Critical
    Pancreatitis is listed as a contraindication on the Cortico Veyxin label.
    Sources: Product label
  • Critical
    A poorly healing wound or fracture is listed as a contraindication on the Cortico Veyxin label.
    Sources: Product label
  • Critical
    General immunodeficiency is listed as a contraindication on the Cortico Veyxin label.
    Sources: Product label
  • Critical
    Gastrointestinal ulceration is an absolute contraindication on all three reviewed labels. Concomitant corticosteroid and NSAID treatment further increases the risk of ulceration; see the interaction warnings.
    Sources: Product label
  • Critical
    cardiac or renal dysfunction
    Sources: Product label
  • Critical
    Severe renal impairment is an absolute contraindication on the Prednicare label.
    Sources: Product label
  • Critical
    Do not use during pregnancy. Some corticosteroid products specify this restriction for the final third of gestation.
  • Warning
    Use in growing animals carries a risk of growth retardation, suppression of bone growth, and damage to the bone matrix.
  • Warning
    Do not use with a live attenuated vaccine because corticosteroids suppress the immune response to vaccination. The Prednicortone label also prohibits use within 2 weeks after vaccination.
  • Warning
    very rare

Known Drug Interactions

  • Contraindicated Meloxicam + Prednisolone
    Concomitant use of corticosteroids and non-steroidal anti-inflammatory drugs can worsen gastrointestinal ulceration.
    Recommendation: Do not administer together. Observe an appropriate washout period when switching and monitor for melena, vomiting, and reduced appetite.
    Sources: Product label
  • Contraindicated Robenacoxib + Prednisolone
    Do not give robenacoxib together with other non-steroidal anti-inflammatory drugs or glucocorticoids because adverse gastrointestinal and renal effects may increase.
    Recommendation: Do not use these drugs together. Allow a treatment-free interval of at least 24 hours after the previous anti-inflammatory drug, extending it when required by that drug’s pharmacokinetics.
  • Major warning Prednisolone + Insulin glargine
    Glucocorticoids, progestogens, and certain endocrinopathies can have an antagonistic effect on insulin activity. Glucocorticoid and progestogen use should be avoided.
    Recommendation: Avoid the combination. If the glucocorticoid cannot be discontinued within 2 weeks, the insulin dose may need to be increased; monitor glycaemia.
    Sources: FDA · AAHA
  • Major warning Prednisolone + Insulin human
    Glucocorticoids, progestogens, and certain endocrinopathies can have an antagonistic effect on insulin activity. Glucocorticoid and progestogen use should be avoided.
    Recommendation: Avoid the combination. If the glucocorticoid cannot be discontinued within 2 weeks, the insulin dose may need to be increased; monitor glycaemia.
    Sources: FDA · AAHA
  • Major warning Furosemide + Prednisolone
    Concurrent use with drugs affecting electrolyte balance (corticosteroids, other diuretics, amphotericin B, cardiac glycosides) requires careful monitoring.
    Recommendation: Monitor electrolytes, particularly potassium. Check periodically during prolonged combination therapy.
    Sources: VMD SPC · VMD
  • Major warning Carprofen + Prednisolone
    Do not give other non-steroidal anti-inflammatory drugs or glucocorticoids concurrently with carprofen or within 24 hours of treatment because gastrointestinal ulceration or perforation may occur.
    Recommendation: Consider appropriate washout times when switching from one NSAID to another or when switching from corticosteroid use to NSAID use.
    Sources: FDA

Products are connected by name, active ingredients, or therapeutic group. They are not direct substitutes for one another.

Show all related products (31 more) Hide additional products

Same active ingredients 2

Same therapeutic group 29

Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.

For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.

Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.

The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.

This reference is still growing. Missing a product? Let us know. · Report an error or request an addition · Updated: 16 Oct 2026

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.

Register Demo ↗